Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Teck Resources (TECK) vs GeneDx Holdings Corp (WGS) Price & Performance

Teck ResourcesTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Teck Resources vs GeneDx Holdings Corp — how do they compare? Teck Resources trades at $70.2 (market cap $35.27B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Teck Resources is far larger — about 13.8× GeneDx Holdings Corp's market cap, and Teck Resources pays a 0.49% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

TECKWGS
Market Cap
$35.27B$2.56B
Sector
IndustrialsTechnology
52-Week High
$71.97$167.51
52-Week Low
$38.23$34.51
Enterprise Value
$37.98B$2.60B
Dividend Yield
0.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Teck Resources

No Aura AI signal available yet.

GeneDx Holdings Corp

WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.

Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.

Returns comparison

Trailing returns across standard periods

About Teck Resources

Teck Resources is a mining company focused on producing metals and minerals, including copper and zinc. Its operations supply materials used in infrastructure, manufacturing, and energy-related industries.

Read more on TECK

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS